Header Logo

Connection

LORENZO COHEN to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications LORENZO COHEN has written about Carcinoma, Hepatocellular.
LORENZO COHEN
Connection Strength
0.119
Carcinoma, Hepatocellular
  1. Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK. Mol Biol Rep. 2012 Feb; 39(2):1683-9.
    View in: PubMed
    Score: 0.041
  2. Na+/K+-ATPase a3 mediates sensitivity of hepatocellular carcinoma cells to bufalin. Oncol Rep. 2011 Mar; 25(3):825-30.
    View in: PubMed
    Score: 0.040
  3. Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 2009 Nov 15; 115(22):5309-18.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.